Moderna (NASDAQ:MRNA – Get Free Report) had its price objective lowered by analysts at JPMorgan Chase & Co. from $40.00 to ...
Shares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) have been assigned an average rating of “Hold” from the twenty-four ...
Goldman Sachs Group Inc. strategists have significantly raised their forecasts for US credit spreads, pointing to tariff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results